Prime Highlights
⦁ Swiss Amcham Chief Executive Rahul Sahgal stated that Switzerland was acting as a model of compliance, asserting that the country fulfils its commitments.
⦁ Despite strong investment momentum, Washington’s new forced-labour tariffs place a 12.5% levy on Swiss goods, higher than the 10% rate applied to EU countries.
Key Facts
⦁ Novartis is a Swiss multinational pharmaceutical company and one of the world’s largest drug makers.
⦁ Switzerland pledged $200 billion in U.S. investments over five years as part of a bilateral tariff deal.
Background
Swiss companies invested $27 billion in the United States between January and April, marking strong early progress toward a $200 billion, five-year investment commitment made under a tariff deal with Washington.
The figures emerged from an internal communication sent by the Swiss-American Chamber of Commerce to its members. Swiss Amcham Chief Executive Rahul Sahgal stated that Switzerland was fulfilling its promises and described the country as a model of compliance.
The $200 billion pledge took shape in mid-November, when Switzerland and the United States reached a preliminary agreement. Under the deal, President Donald Trump reduced tariffs on Swiss goods to 15%, down from 39%, which Washington had imposed in early August.
Several major Swiss firms are driving the investment push. Pharmaceutical giant Novartis is funding two U.S. projects, a biomedical research centre in San Diego and a cancer-drug production facility in Texas. Fellow healthcare company Roche is expanding its output in North Carolina, while medical technology firm Ypsomed is building a new factory in the same state.
Beyond healthcare, shipping group MSC has established its new North American headquarters in Miami, covering cruise and logistics operations. Industrial firms Pfiffner Group and Elma are also scaling up U.S. production capacity.
However, a new complication has emerged. Washington recently announced fresh tariffs targeting countries it accuses of insufficient action against forced labour. Switzerland faces a 12.5% levy under this measure, slightly above the 10% rate applied to European Union goods, introducing new friction despite the broader investment momentum.
